日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The CXCL10-CXCR3 Axis Induces Tumor-Associated Neutrophils to Interfere with CTLs-Mediated Antitumor Activity in EBV-Associated Epithelial Cancers.

CXCL10-CXCR3轴诱导肿瘤相关中性粒细胞干扰CTL介导的EBV相关上皮癌的抗肿瘤活性。

Ouyang Dijun, Xiang Tong, Chen Yuanyuan, Song Mengjia, Zhao Jingjing, Chen Hao, Li Si, Zhang Lifeng, Xu Chi, Ren Yan, Tao Yong, Wang Qijing, He Jia, Li Yongqiang, Xie Sisi, Liu Yuanyuan, Wang Yan, Yang Xinyi, You Jinqi, Xie Songzuo, Li Yingzi, Weng Desheng, Pan Qiuzhong, Yang Qi, Xia Jianchuan

Long-term survival after local immunotherapy for malignant gliomas: a retrospective study with 20 years follow-up.

恶性胶质瘤局部免疫治疗后的长期生存率:一项回顾性研究,随访时间长达 20 年

Duan Hao, He Zhenqiang, Chen Zhenghe, Chen Yukun, Hu Wanming, Sai Ke, Zhang Xiangheng, Xia Jianchuan, Li Yongqiang, Liu Ranyi, Zou Chaowei, Chen Zhongping, Mou Yonggao

BMP9-induced vascular normalisation improves the efficacy of immunotherapy against hepatitis B virus-associated hepatocellular carcinoma.

BMP9 诱导的血管正常化可提高针对乙型肝炎病毒相关肝细胞癌的免疫疗法的疗效

Han Yulong, Pan Qiuzhong, Guo Zhixing, Du Yufei, Zhang Yaojun, Liu Yingying, Zhao Jingjing, Xu Jinfeng, Yang Jieying, Ouyang Dijun, Tang Yan, Wang Qijing, Li Yongqiang, He Jia, Yang Mengjuan, Chen Hao, Yang Chaopin, Yang Xinyi, You Jinqi, Chen Yuanyuan, Ren Minghao, Zhu Yao, Xia Jianchuan, Xiang Tong

Survival Improvement in Patients with Renal Cell Carcinoma and Disparities between Different Sexes, Races, and Socioeconomic Status: 1977-2016

肾细胞癌患者生存率的提高及其在不同性别、种族和社会经济地位群体间的差异:1977-2016年

Ouyang, Dijun; Sun, Huanhuan; Chen, Nan; Yan, Yan; Ma, Haiqing; Xia, Jianchuan

Identification of Key Genes With Differential Correlations in Lung Adenocarcinoma

肺腺癌中差异相关性关键基因的鉴定

Zhou, You; Xu, Bin; Zhou, Yi; Liu, Jian; Zheng, Xiao; Liu, Yingting; Deng, Haifeng; Liu, Ming; Ren, Xiubao; Xia, Jianchuan; Kong, Xiangyin; Huang, Tao; Jiang, Jingting

Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma

新辅助帕唑帕尼或阿昔替尼联合程序性死亡蛋白-1激活的树突状细胞-细胞因子诱导的杀伤细胞免疫疗法可能有助于肾细胞癌患者的手术。

Zhang, Zhiling; Xiong, Longbin; Wu, Zeshen; Liu, Huiming; Ning, Kang; Peng, Yulu; Yu, Chunping; Ding, Ya; Weng, Desheng; Xia, Jianchuan; Jiang, Lijuan; Guo, Shengjie; Han, Hui; Zhou, Fangjian; Dong, Pei

Severe delayed pulmonary toxicity following PD-L1-specific CAR-T cell therapy for non-small cell lung cancer

非小细胞肺癌患者接受PD-L1特异性CAR-T细胞治疗后出现严重的迟发性肺毒性

Liu, Heping; Ma, Yuxiang; Yang, Chaopin; Xia, Shangzhou; Pan, Qiuzhong; Zhao, Hongyun; Fang, Wenfeng; Chen, Xi; Zhang, Yang; Zou, Benyan; Li, Qiuyuan; Wan, Yang; Chen, Hao; Tang, Yan; Zhao, Jingjing; Weng, Desheng; Xia, Liming; Zhang, Li; Xia, Jianchuan

Anti-αFR CAR-engineered NK-92 Cells Display Potent Cytotoxicity Against αFR-positive Ovarian Cancer

抗αFR CAR工程化NK-92细胞对αFR阳性卵巢癌表现出强大的细胞毒性

Ao, Xiang; Yang, Yu; Li, Weiqiang; Tan, Yan; Guo, Wei; Ao, Luoquan; He, Xiao; Wu, Xiaofeng; Xia, Jianchuan; Xu, Xiang; Guo, Jianxin

SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma

SKA1 过表达与肝细胞癌预后不良相关

Chen, Yibing; Zhao, Jingjing; Jiao, Zhihui; Wang, Weiwei; Wang, Dandan; Yu, Xiaohe; Shi, Zhiyong; Ge, Naijian; Pan, Qiuzhong; Xia, Jianchuan; Niu, Wancheng; Zhao, Ruihua; Zhang, Xiaofei; Du, Wei

IL-17A promotes migration and tumor killing capability of B cells in esophageal squamous cell carcinoma.

IL-17A 促进食管鳞状细胞癌中 B 细胞的迁移和肿瘤杀伤能力

Lu Lin, Weng Chengyin, Mao Haibo, Fang Xisheng, Liu Xia, Wu Yong, Cao Xiaofei, Li Baoxiu, Chen Xiaojun, Gan Qinquan, Xia Jianchuan, Liu Guolong